Evidence map›Paper›PMID 32802523›Full record

ArticleCase reports in critical care2020

Critical Care Management for Novel 2019 SARS-CoV-2 and HCoV-NL63 Coinfection in a Young Immunocompromised Patient: A Chicago Experience.

Alejandro Sanchez-Nadales, Miguel Treminio-Quezada, Hasan Abad, Jessica Navarro-Motta, Pamela Contreras-Chavez, Anil Kachru, Chae Chu

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Case reports in critical care, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Alejandro Sanchez-NadalesDepartment of Medicine, Advocate Illinois Masonic Medical Center, Chicago, IL 60657, USA.ORCID https://orcid.org/0000-0003-1531-5032
Miguel Treminio-QuezadaDepartment of Medicine, Advocate Illinois Masonic Medical Center, Chicago, IL 60657, USA.
Hasan AbadDepartment of Medicine, Advocate Illinois Masonic Medical Center, Chicago, IL 60657, USA.
Jessica Navarro-MottaDepartment of Medicine, Advocate Illinois Masonic Medical Center, Chicago, IL 60657, USA.
Pamela Contreras-ChavezDepartment of Medicine, Advocate Illinois Masonic Medical Center, Chicago, IL 60657, USA.
Anil KachruDepartment of Pulmonology and Critical Care Medicine, Advocate Illinois Masonic Medical Center, Chicago, IL 60657, USA.
Chae ChuDepartment of Pulmonology and Critical Care Medicine, Advocate Illinois Masonic Medical Center, Chicago, IL 60657, USA.
Advocate Illinois Masonic Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSARS-CoV-2 is a newly emerged virus that has spread rapidly, exhibiting tremendous morbidity and mortality. Some potential pharmaceutical targets have been identified but are still lacking proper validation.

conclusionCoinfection with other respiratory pathogens and opportunistic infections are possible.

Identifiers

PMID32802523
PMCPMC7415109
OpenAlexW3046565628

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.